Drugmaker Lupin said on Wednesday it had received preliminary approval from US health regulators to sell Ivacaftor tablets for cystic fibrosis in the US. In...
Pharmaceutical company Lupin said on Monday it had received approval from US health regulators to market its Tenofovir Alafenamide tablets to treat chronic hepatitis B...
India’s top pharmaceutical majors, including Sun Pharma, Cadila Healthcare, Lupin, and Torrent Pharma, are in talks to acquire business-to-business healthcare platform Pharmarack, according to multiple...
EquityPandit’s Outlook for Lupin for the week (July 27,2020 – July 31, 2020) LUPIN: BSE: 500257| NSE: LUPIN| ISIN: INE326A01037| SECTOR: PHARMA Stock closed the...
EquityPandit’s Outlook for Lupin for the week (July 20,2020 – July 24, 2020) LUPIN: BSE: 500257| NSE: LUPIN| ISIN: INE326A01037| SECTOR: PHARMA Stock closed the...
EquityPandit’s Outlook for Lupin for the week (July 13,2020 – July 17, 2020) LUPIN: BSE: 500257| NSE: LUPIN| ISIN: INE326A01037| SECTOR: PHARMA Stock closed the...
EquityPandit’s Outlook for Lupin for the week (June 29, 2020 – July 03, 2020) LUPIN: BSE: 500257| NSE: LUPIN| ISIN: INE326A01037| SECTOR: PHARMA Stock closed...
EquityPandit’s Outlook for Lupin for the week (June 22, 2020 – June 26, 2020) LUPIN: BSE: 500257| NSE: LUPIN| ISIN: INE326A01037| SECTOR: PHARMA Stock closed...
EquityPandit’s Outlook for Lupin for the week (June 15, 2020 – June 19, 2020) LUPIN: BSE: 500257| NSE: LUPIN| ISIN: INE326A01037| SECTOR: PHARMA Stock closed...
EquityPandit’s Outlook for Lupin for the week (June 8, 2020 – June 12, 2020) LUPIN: BSE: 500257| NSE: LUPIN| ISIN: INE326A01037| SECTOR: PHARMA Stock closed...